By: Christina Klemm, Pharm.D., BCACP, Clinical Pharmacist, Enlyte The U.S. Food and Drug Administration (FDA) recently approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate to severe acute pain in […]

Denver, CO (WorkersCompensation.com) -- At the 2023 National Counsel of Self-Insurers 76th Annual Meeting & Conference on June 5, Phil Walls, Chief Clinical Officer of MyMatrixx, took the stage to address the attendees on "The […]